Predictors of achieving a minimal clinically important difference in lower urinary tract symptoms 3-months after Rezum therapy

Gaining insight into patient characteristics to predict the success of procedures is crucial for improving outcomes and for preoperative counselling. We identified predictors of achieving a minimal clinically important difference (MCID) in lower urinary tract symptoms (LUTS) 3 months after Rezūm.